Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Exendin improves β-cell response in subjects with impaired glucose tolerance

Exendin improves β-cell response in subjects with impaired glucose tolerance

US Patent 7265087 · Granted Sep 4, 2007

Estimated economic value: $41,304,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of hibernating myocardium with an exendin peptide2013
Peptide derivatives of exendin-42012
Method of performing angioplasty with a GLP-1 molecule2011
Compositions and methods for treating peripheral vascular disease2011
Metabolic intervention with GLP-1 or its biologically active analogues to improv2010
Compositions and methods for treating peripheral vascular disease2007
Treatment of acute coronary syndrome with GLP-12006
Human appetite control by glucagon-like peptide receptor binding compounds2006
Human appetite control by glucagon-like peptide receptor binding compounds2006
Metabolic intervention with GLP-1 to improve the function of ischemic and reperf2006
Treatment of hibernating myocardium and diabetic cardiomyopathy with a GLP-1 pep2005
Exendin analogues, processes for their preparation and medicaments containing th2004